PubRank

J M Fournier

Author PubWeight™ 66.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol 1993 4.36
2 Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J Clin Microbiol 1987 3.17
3 Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide. Infect Immun 1984 3.14
4 Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol 1985 2.97
5 Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 1989 2.30
6 Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J Clin Microbiol 1988 1.87
7 Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun 2000 1.68
8 Direct testing of blood culture for detection of the serotype 5 and 8 capsular polysaccharides of Staphylococcus aureus. J Clin Microbiol 1989 1.61
9 One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Diagn Lab Immunol 2003 1.54
10 Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol 1990 1.54
11 Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol 1988 1.50
12 Structure of the type 5 capsular polysaccharide of Staphylococcus aureus. Carbohydr Res 1990 1.44
13 Occurrence of pathogenic vibrios in coastal areas of France. J Appl Microbiol 2002 1.43
14 The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis 1994 1.43
15 Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs. J Clin Microbiol 2003 1.42
16 Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo. J Infect Dis 1997 1.38
17 Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media. Appl Environ Microbiol 1991 1.36
18 Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun 1981 1.33
19 Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol 1993 1.33
20 Epidemiological markers for epidemic strain and carrier isolates in an outbreak of nosocomial oxacillin-resistant Staphylococcus aureus. J Clin Microbiol 1990 1.29
21 Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic medium. J Gen Microbiol 1991 1.28
22 On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J Biol Chem 1998 1.25
23 Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992 1.23
24 Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett 1999 1.22
25 Optical matter: crystallization and binding in intense optical fields. Science 1990 1.22
26 Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci U S A 2000 1.21
27 Cholera in Madagascar. Lancet 1999 1.16
28 Regulation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides by CO(2). J Bacteriol 2001 1.12
29 Emergence of cholera in the Central African Republic. Eur J Clin Microbiol Infect Dis 1998 1.07
30 Diagnosing Staphylococcus aureus endocarditis by detecting antibodies against S. aureus capsular polysaccharide types 5 and 8. J Infect Dis 1991 1.05
31 Nontoxigenic vibrio Cholerae O1 bacteremia: case report and review. Eur J Clin Microbiol Infect Dis 2000 1.04
32 Reactivity of coagulase-negative staphylococci isolated from cow and goat milk with monoclonal antibodies to Staphylococcus aureus capsular polysaccharide types 5 and 8. J Clin Microbiol 1990 1.02
33 Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations. Infect Immun 1981 1.01
34 Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus. Infect Immun 1996 1.00
35 Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect Immun 2001 0.97
36 Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1. Microbiology 1999 0.96
37 Epidemiology of Staphylococcus aureus in patients with cystic fibrosis. Epidemiol Infect 1994 0.94
38 Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun 1979 0.93
39 Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents. J Clin Microbiol 1991 0.92
40 Comparison of various methods and reagents for species identification of Staphylococcus aureus positive or negative for the mecA gene. APMIS 1993 0.90
41 Nonlinear identification of NMR spin systems by adaptive filtering. J Magn Reson 2000 0.88
42 [Fetal and neonatal transmission of type-b anti-haemophilus influenzae antibodies protecting the newborn rat]. Pathol Biol (Paris) 1983 0.83
43 Comparison between lactoferrin and subepithelial matrix protein binding in Staphylococcus aureus associated with bovine mastitis. J Dairy Sci 1991 0.82
44 [Influence of different types of experimental obesity on resistance of the mouse to infection by Salmonella typhimurium and Klebsiella pneumoniae]. Ann Nutr Metab 1988 0.80
45 Septicemia due to non-O:1 Vibrio cholerae in a patient with AIDS. Clin Infect Dis 1994 0.80
46 Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid. Infect Immun 1981 0.79
47 Glucose-induced activation of rubidium transport and water flux in sunflower root systems. J Exp Bot 2001 0.79
48 [Isolation of Vibrio strains in French coastal waters and infection with Vibrio cholerae non-O1/non-O139]. Presse Med 2001 0.76
49 [Experimental airborne A-Hong-Kong-1-68 (H3N2) influenza bronchopneumonia in Balb-c mouse. Histopathological, immunofluorescent and ultrastructural studies (author's transl)]. Beitr Pathol 1974 0.75
50 Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide. Infect Immun 1986 0.75
51 Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts. Med Microbiol Immunol 1984 0.75
52 Dry aerosol vaccination against Newcastle disease: II. Serological response in chicks. Dev Biol Stand 1976 0.75
53 [Detection of heterogeneous Staphylococci by the Autobac system using a nafcillin disk]. Pathol Biol (Paris) 1988 0.75
54 Adsorption-desorption and leaching of phenylurea herbicides on soils. Talanta 1996 0.75
55 [Vaccination of the cinocephal monkey Papio papio against plague with a Yersinia pestis EV strain supernatant]. C R Acad Sci Hebd Seances Acad Sci D 1973 0.75
56 [Study in mice of the protective power of the EV strain of Yersinia pestis and of its culture supernatant]. C R Acad Sci Hebd Seances Acad Sci D 1972 0.75
57 [Anti-lipoteichoic acid antibodies in 45 cystic fibrosis patients with Staphylococcus aureus infection]. Presse Med 1991 0.75
58 [Immunization with aerosols. IV. Perfecting equipment of production of vaccine aerosols]. Ann Inst Pasteur (Paris) 1970 0.75
59 [Regulation of Staphylococcus aureus capsular polysaccharide type 5: in vitro and in vivo inhibition by CO2]. Pneumologie 1997 0.75
60 [Resistance of Vibrio cholerae 0:1 to the 0/129 compound and multiresistance to antibiotics]. Bull Soc Pathol Exot 1992 0.75
61 [Isolation and description of a vaccinating antigen present in the culture supernatant of Yersinia pestis (strain EV-40)]. C R Acad Sci Hebd Seances Acad Sci D 1973 0.75
62 [In vitro sensitivity of Vibrio cholerae serotype 0:139 to an intestinal antiseptic tiliquinol-tilbroquinol combination]. Bull Soc Pathol Exot 1994 0.75
63 [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1]. Bull Soc Pathol Exot 1994 0.75
64 [Immunization with aerosols. 3. Equipment of production and control of pulverulent antigen aerosols]. Ann Inst Pasteur (Paris) 1970 0.75
65 [Cholera in a Paris resident with no history of travel. A case report]. Presse Med 1998 0.75
66 [Simplified vibriocidal antibody titer performed on a drop of blood]. Bull Soc Pathol Exot 1993 0.75
67 [Bacteriological aspects of cholera in Chad (1991 and 1994 epidemics)]. Bull Soc Pathol Exot 1995 0.75
68 Dry aerosol vaccination against Newcastle disease. I. Safety and activity controls on chickens. Dev Biol Stand 1976 0.75
69 [Immunization by aerosols. VII. Vaccination of baboons by lyophilized tetanus anatoxin and by a mixture of tetanus and diphtheria anatoxin]. Ann Inst Pasteur (Paris) 1971 0.75